Kevin Lalande

Prior to founding Santé Ventures, Kevin spent seven years with Austin Ventures, a prominent venture firm with $3.9 billion under management. Before joining Austin Ventures, he was a management consultant with McKinsey & Company. Previously, Kevin co-founded and sold three successful start-up companies: NetProfit, sold to a privately held advertising agency in 1996; Serus, sold to Netopia (Nasdaq: NTPA) in 1998; and TimeMarker, sold to PrimeHoldings (OTCBB: PRIM) in 2001. Kevin received an MBA with highest distinction (Baker Scholar) from the Harvard Business School and holds a BS in Electrical and Computer Engineering.

J. David Enloe

J. David Enloe Jr. is President and CEO of Vivante GMP Solutions, Inc., a company which provides process development, scale-up and GMP manufacturing of biologics for clients in the US, Europe and Japan. Prior to helping found Vivante, Mr. Enloe was with Introgen Therapeutics, Inc. for over 14 years, joining as that company’s first full-time employee and rising in responsibility over time to COO for several years before ultimately serving as Introgen’s President and CEO. From 1989 to 1995, he held various positions at a division of Baker Hughes, Inc., an energy services company, including Region General Manager, Southeast Asia, and he worked at Arthur Andersen LLP as an accountant prior to that time. Mr. Enloe is a Certified Public Accountant and received his B.B.A. in accounting from The University of Texas at Austin.

Casey Cunningham, MD

Curt Bilby